Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research

Quintiles is the industry leader that best differentiates itself on service quality in Phase II/III clinical research, according to 157 pharmaceutical and biotechnology professionals who responded to Industry Standard Research’s (ISR) 2013"......

Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that results from a prospective, multicenter, randomized, controlled clinical trial show that endoscopic ablation therapy using the Barrx™ RF Ablation System is effective at eliminating Barrett’s esophagus, a pre-cancerous condition of"......

Phase III results: tiotropium* Respimat® effective in symptomatic asthma patients despite at least ICS†/LABA‡ independent of their age, allergic status, smoking status and bronchodilator response

• Tiotropium delivered by the Respimat® SoftMistTM Inhaler increases time to first severe exacerbation and first episode of asthma worsening across a broad spectrum of patients who remain symptomatic despite at least ICS/LABA therapy
• The improvements in lung function with tiotropium were specific to asthma patients; as a co-morbid condition,...
  Continue Reading

Arthur D. Little creates strategy for healthcare launch excellence

After years of low productivity, R&D in leading pharmaceutical and biotech companies is starting to deliver on its promises; the number of New Molecular Entities (NMEs) approved by the US FDA has leveled out and biotech companies’ share prices are rising, indicating profitable"...

New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System

Kinetic Concepts, Inc. announced today that ABThera™ Open Abdomen Negative Pressure Therapy System (ABThera™ OA NPT) was associated with significantly improved patient outcomes compared to traditional Barker’s vacuum-packing technique (BVPT) in trauma and surgical patients studied. Results of the observational study, “Prospective"......

Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock

Quintiles today announced the completion of its initial public offering of 27,236,841 shares of its common stock at a price to the public of $40.00 per share. Quintiles offered and sold 13,125,000 shares of common stock in the offering and selling shareholders offered and sold 14,111,841"...

ASCO 2013: New Phase III data reveal targeted treatment with afatinib* or with nintedanib* improves progression-free survival in patients with advanced NSCLC

Growing body of clinical data supports superiority of the irreversible ErbB Family Blocker afatinib* over standard chemotherapy (with combination of cisplatin and gemcitabine or pemetrexed) for first-line treatment of patients with EGFR-mutation positive advanced NSCLC

Merck Serono and Quintiles Announce Innovative Clinical Development Partnership

Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, today announced a new, five-year clinical development agreement. This strategic collaboration is the first-of-its-kind between a biopharmaceutical company and a biopharmaceutical services...

New evidence establishes EPA as highly predictive of skin graft failure and supports the utility of Systagenix WOUNDCHEK™ Protease Status point of care test in this application

New evidence presented on Wednesday 15th May 2013 at the European Wound Management Association (EWMA)’s conference in Copenhagen, revealed that elevated protease activity"......

Lincor Solutions Launches World’s First Mobile Solution for Patient Engagement and Clinical Services

Lincor Solutions Launches World’s First Mobile Solution for Patient Engagement and Clinical Services

MEDIVista MOBILE delivers services to Apple iPad and Android devices

eHealth Week